/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

Medpace Holdings, Inc.

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$576.48 -0.0124(-1.24%) MEDP at 04 Dec 2025 04:38 PM Diagnostics & Research
Lowest Today 571.54
Highest Today 590
Today’s Open 589.68
Prev. Close 583.7
52 Week High 626.26
52 Week Low 250.05
Day’s Range: Low 571.54 High 590
52-Week Range: Low 250.05 High 626.26
1 day return -
1 Week return -2.95
1 month return -3.12
3 month return +19.44
6 month return +84.0
1 year return +66.57
3 year return +180.14
5 year return +318.67
10 year return -

Institutional Holdings

BlackRock Inc 8.77

Vanguard Group Inc 8.51

Wasatch Advisors LP 3.37

Mawer Investment Management Ltd 2.91

iShares Core S&P Mid-Cap ETF 2.73

Vanguard Total Stock Mkt Idx Inv 2.57

State Street Corp 2.52

Renaissance Technologies Corp 2.41

Geode Capital Management, LLC 2.27

AQR Capital Management LLC 2.21

Vanguard Small Cap Index 1.99

Baillie Gifford & Co Limited. 1.86

Bessemer Group Inc 1.81

Morgan Stanley - Brokerage Accounts 1.74

TD Asset Management Inc 1.63

Invesco World Dev Countries Eq Mother 1.62

Amvescap Plc. 1.61

TD Global Investment Solutions – TD Epoch 1.58

Riverbridge Partners LLC 1.55

Dimensional Fund Advisors, Inc. 1.47

Millennium Management LLC 1.23

D. E. Shaw & Co LP 1.22

Invesco S&P MidCap Quality ETF 1.21

Northern Trust Corp 1.20

Vanguard Small Cap Growth Index Inv 1.12

Jane Street Group LLC 1.11

Findlay Park American I USD Dist 1.09

Vanguard Explorer Inv 0.97

Vanguard Institutional Extnd Mkt Idx Tr 0.90

Wasatch Core Growth 0.78

Mawer Global Equity A 0.65

SPDR® S&P MIDCAP 400 ETF Trust 0.64

TD Epoch Glb Qlty Capital Reinvestment 0.63

TD Global Capital Reinvestment - I 0.62

Madison Mid Cap Y 0.55

iShares Russell Mid-Cap Growth ETF 0.54

Wasatch Small Cap Growth Investor 0.52

Manulife Global Equity Class F 0.51

TD U.S. Capital Reinvestment I 0.51

iShares Biotechnology ETF 0.50

Market Status

Strong Buy: 2

Buy: 0

Hold: 10

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 16441.79 M

PB Ratio 56.8332

PE Ratio 41.1636

Enterprise Value 16522.26 M

Total Assets 2100.87 M

Volume 245168

Company Financials

Annual Revenue FY24:2109054000 2109.1M, FY23:1781539000 1781.5M, FY22:1459996000 1460.0M, FY21:1142377000 1142.4M, FY20:925925000 925.9M

Annual Profit FY24:656305000 656.3M, FY23:503430000 503.4M, FY22:432438000 432.4M, FY21:328155000 328.2M, FY20:278726000 278.7M

Annual Net worth FY24:404386000 404.4M, FY23:273182000 273.2M, FY22:245368000 245.4M, FY21:181848000 181.8M, FY20:145384000 145.4M

Quarterly Revenue Q3/2025:659903000 659.9M, Q2/2025:603311000 603.3M, Q1/2025:558570000 558.6M, Q4/2024:536589000 536.6M, Q3/2024:533317000 533.3M

Quarterly Profit Q3/2025:196939000 196.9M, Q2/2025:180013000 180.0M, Q1/2025:178350000 178.4M, Q4/2024:178317000 178.3M, Q3/2024:169008000 169.0M

Quarterly Net worth Q3/2025:111135000 111.1M, Q2/2025:90260000 90.3M, Q1/2025:114595000 114.6M, Q4/2024:117018000 117.0M, Q3/2024:96426000 96.4M

Fund house & investment objective

Company Information Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Organisation Diagnostics & Research

Employees 6200

Industry Diagnostics & Research

CEO Dr. August James Troendle M.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow